Trial ID: | L0615 |
Source ID: | IRCT201309188308N3
|
Associated Drug: |
N-Acetylsyctein
|
Title: |
Comparison of the effectivness of N-Acetylsyctein, Pioglitazon and Metformin in the treatment of non alcoholic fatty liver disease
|
Acronym: |
--
|
Status: |
Not Recruiting
|
Study Results: |
No Results Available
|
Results: |
--
|
Conditions: |
Non Alcoholic Fatty Liver Disease. <br>Nonalcoholic steatohepatitis;Nonalcoholic steatohepatitis
|
Interventions: |
Intervention 1: Third group: metformin tablets 500 mg every 12 hours for two months. Intervention 2: Second group pioglitazone 30 mg tablets for two months. Intervention 3: First group: N-acetylcysteine 600 mg tablets for two months.;Treatment - Drugs;Tre
|
Outcome Measures: |
Liver enzymes. Timepoint: two month. Method of measurement: Labratory.Grading of Steatosis. Timepoint: two month. Method of measurement: Sonography.
|
Sponsor/Collaborators: |
Vice Chancellor for Research and Technology University of Medical Sciences of Hamedan
|
Gender: |
All
|
Age: |
20 years80 years
|
Phases: |
Phase 3
|
Enrollment: |
60
|
Study Type: |
interventional
|
Study Designs: |
Randomization: Randomized, Blinding: Double blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment.
|
Start Date: |
23/02/2015
|
Completion Date: |
--
|
Results First Posted: |
--
|
Last Update Posted: |
22 February 2018
|
Locations: |
Iran (Islamic Republic of)
|
URL: |
http://en.irct.ir/trial/8754
|